NCT06904495 Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age
| NCT ID | NCT06904495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Cancer Survivors |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2026-05-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2025-04-15 with a primary completion date of 2026-05-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Medical professionals now take into account the specificities of the care and support of Adolescents and Young Adults (AYAs). Cancer aftermaths in patients diagnosed during the AYA period are also known: the consequences of chemotherapy and radiotherapy treatments on a growing organism, the difficulty of some follow-ups, the longevity, and the delayed occurrence of certain complications. In the general population, sleep disorders affect 40% of adolescents. About 30% of pediatric cancer survivors experience fatigue they attribute to their cancer, even years after the end of their treatment. The sleep quality of patients treated for cancer when they were AYAs, and the eventual care of sleeping disorders, are poorly studied. The investigators suppose that the oncologic treatment during this particular life stage, when sleeping disorders are already present and multifactorial, could have long-term impacts on sleep. The investigators offer to evaluate, through a questionnaire filled out by patients treated for cancer in the AYA period, the frequency of moderate to severe insomnia.
Eligibility Criteria
Inclusion Criteria: * Patient treated for a cancer * Patient aged between 15 and 24 years old at the time of the diagnosis * Patients whom intensive treatment ended at least 3 months ago * Patient followed in a PACAAURA cancerology center * Life expectancy ≥ 6 months * Karnosky index \> 60% * Patient who agrees to participate in the program and benefits from social security * Patient able to understand, speak and read French. * No major cognitive impairment (assessed by the patient's referees) * No sensory disability Exclusion Criteria: * Patient unable to use informatic tools * Known superior cognitive function disorders * Progressive psychiatric pathology * Drug user or alcohol abuse
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06904495 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 24 Years, studying Cancer Survivors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06904495 currently recruiting?
Yes, NCT06904495 is actively recruiting participants. Contact the research team at horwitez.m@chu-nice.fr for enrollment information.
Where is the NCT06904495 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT06904495 clinical trial?
NCT06904495 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.